← Back to Search

Prognosis information and Provider Scripts for Cancer Screening

N/A

Waitlist Available

Led By Mara A Schonberg, MD, MPH

Research Sponsored by Beth Israel Deaconess Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 18 months

Awards & highlights

Study Summary

This trial will test whether providing doctors with scripts on patient prognosis and patients with information on their prognosis would be useful when recommending stopping cancer screening for older adults.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 18 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 18 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Intentions to be Screened for Colorectal Cancer.

Secondary outcome measures

Difference in PCP experiences

Discussion of stopping cancer screening and prognosis

PCP Barriers

+3 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Prognosis Information and Provider ScriptsExperimental Treatment1 Intervention

Investigators will send the PCP via secure email the patient's prognosis calculated by the Lee-Schonberg index three days before the patient visit. Investigators will also send PCPs information on patient life expectancy from Cho et al.'s US life tables and scripts developed to sensitively include information on patient prognosis when recommending patients stop being screened for cancer. After five of their patients have participated or recruitment goals are met, investigators will ask PCPs to complete a 10 minute web-based questionnaire about their experience.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH

13,657 Previous Clinical Trials

40,933,577 Total Patients Enrolled

Beth Israel Deaconess Medical CenterLead Sponsor

836 Previous Clinical Trials

13,010,246 Total Patients Enrolled

Mara A Schonberg, MD, MPHPrincipal InvestigatorBeth Israel Deaconess Medical Center

1 Previous Clinical Trials

541 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are elderly individuals being included in the recruitment of this trial?

"Per the qualifications of this clinical trial, prospective participants must be within a certain age range; 76 years old being the minimum and 89 as the maximum."

Answered by AI

Who fulfills the eligibility criteria for this research study?

"This medical trial is permitting 90 cancer sufferers aged from 76 to 89 the opportunity to participate. Those interested must meet certain criteria, such as being English-speaking and having undergone CRC screening within 10 years for those between 76 and 79 who have at least one Charlson Comorbidity. Additionally, females should possess proof of a mammography screen within 3 years prior. Finally, all participants should be in line for a routine visit or physical with their primary care physician (PCP) during the next three to twelve weeks."

Answered by AI

Are there any vacancies left in this clinical trial?

"Based on the information available on clinicaltrials.gov, this medical trial is not currently enrolling patients. The listing was originally published in October 2017 and updated at the end of July 2021. Nonetheless, there are 3 additional studies with open recruitment slots for individuals interested in participating."

Answered by AI

Recent research and studies

Innovation in AgingJournal

A Strategy to Prepare Primary Care Clinicians for Discussing Stopping Cancer Screening with Adults Older Than 75 Years

Schonberg, Mara A, Maria Karamourtopoulos, Alicia R Jacobson, Gianna M Aliberti, Adlin Pinheiro, Alexander K Smith, Roger B Davis, Linnaea C Schuttner, and Mary Beth Hamel. 2020. “A Strategy to Prepare Primary Care Clinicians for Discussing Stopping Cancer Screening with Adults Older Than 75 Years”. Edited by Michael Weiner. Innovation in Aging. Oxford University Press (OUP). doi:10.1093/geroni/igaa027.

clinicaltrials.govStudy

Discussing Stopping Cancer Screening and Prognosis With Older Adults

Mara Schonberg 2017. "Discussing Stopping Cancer Screening and Prognosis With Older Adults". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03480282.